Ciprofloxacin Dosing for ENT Infections
For most ENT infections requiring ciprofloxacin, use 500-750 mg orally twice daily for adults, with specific dosing depending on the infection type and severity.
Dosing by Infection Type
Acute Otitis Externa (Outer Ear Canal Infection)
- Topical ciprofloxacin 0.3% otic drops is the preferred route 1
- Oral dosing: 500 mg twice daily if systemic therapy needed 2, 3
- Topical therapy is significantly more effective than oral for ear infections 4, 5, 6
Chronic Suppurative Otitis Media (Middle Ear Infection with Perforation)
- Topical ciprofloxacin 0.2-0.5% drops twice daily for 5-10 days 4, 5
- If oral therapy required: 250-500 mg twice daily 5, 7
- Critical point: Topical administration achieves 95% bacteriological eradication versus only 40% with oral therapy 5
- For chronic otitis, topical therapy demonstrates superior outcomes compared to systemic administration 6
Malignant External Otitis (Severe Pseudomonas Infection)
- 750 mg orally twice daily for approximately 3 months 8
- Alternative: 200 mg IV twice daily for severe cases 8
- This serious infection requires prolonged therapy with 96.4% clinical cure rate at this dosing 8
Pharyngotonsillitis (Throat Infection)
- 250 mg orally twice daily for 5-10 days 9
- Reserve for cases where conventional antibiotics have failed due to resistance
- Achieves 92% favorable clinical response 9
Bite Wounds (Animal or Human)
- 500-750 mg orally twice daily 2, 3
- Alternative: 400 mg IV every 12 hours 2, 3
- Provides excellent activity against Pasteurella multocida (animal bites) and Eikenella corrodens (human bites)
Pediatric Dosing
For children when fluoroquinolones are necessary (despite FDA cautions):
- 10-15 mg/kg every 12 hours orally (maximum 1 g/day) 10, 11
- 20-30 mg/kg/day IV divided every 8-12 hours (maximum 400 mg/dose) 11
Key Clinical Considerations
Route selection matters significantly: For ear infections, topical ciprofloxacin achieves bacteriological eradication rates of 83-95% compared to only 40-65% with oral therapy 4, 5. The assumption that high topical concentrations overcome resistance is incorrect—ciprofloxacin-resistant bacteria show only 2.7% cure with topical ciprofloxacin versus 70% with alternative agents 12.
Resistance patterns: If ciprofloxacin resistance is documented, switch to alternative therapy immediately. Continuing ciprofloxacin (even topically) against resistant organisms is ineffective 12. The most common resistant organisms in ENT infections are MRSA (33%), Corynebacterium striatum (19%), and non-MRSA Staphylococcus aureus (11%) 12.
Duration: Most acute ENT infections require 5-10 days of therapy 4, 5, 9, except malignant external otitis which requires approximately 3 months 8.
Common pitfall: Do not use oral ciprofloxacin as first-line for simple ear infections when topical therapy is appropriate—you'll achieve worse outcomes with unnecessary systemic exposure and resistance risk 5, 6.